Proposal to list cinacalcet (Sensipar) on the Pharmaceutical Schedule for parathyroid carcinoma and calciphylaxis

11 March 2016 - PHARMAC is seeking feedback on a proposal to list cinacalcet (Sensipar) on the Pharmaceutical Schedule through a provisional agreement with Amgen Australia Pty Limited from 1 May 2016.

For more details, go to: http://www.pharmac.govt.nz/news/consultation-2016-03-11-cinacalcet/

Michael Wonder

Posted by:

Michael Wonder